Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

For patients with inadequately controlled T2D receiving dulaglutide, switching to tirzepatide is associated with additional HbA1c reduction and weight loss.

Although the administration method seems ideal for prehospital use, the complexities of stroke assessment — including CT imaging and neurologist evaluation — still limit EMS adoption. Mechanical ...